Deep 6 AI is a fast-growing tech startup founded in 2016, on a mission to bring life-saving treatments to patients faster with AI in clinical trials. Their Precision Research Ecosystem connects researchers, physicians, sponsors, and CROs to advance research faster than the speed of disease.

Deep 6 AI

Accelerated Enrollment Solutions (AES) provides services to biopharmaceutical and biotechnology companies for patient recruitment and research site management.

Accelerated Enrollment Solutions (AES)

Massive Bioinformatics provides bioinformatics and biotechnology solutions aimed at enhancing the quality of life through innovative products and services, self-described as a team of dedicated scientists and software engineers.

Massive Bioinformatics

OneStudyTeam builds solutions that connect and empower the clinical trial ecosystem, offering a cloud-based platform, StudyTeam, that simplifies site workflows while providing sponsors with visibility into recruitment and enrollment progress.

OneStudyTeam

Deep 6 AI disrupts the clinical trial enrollment process by transforming the way researchers identify eligible patients. Using artificial intelligence and natural language processing to mine structured and unstructured patient data, DEEP 6 AI finds more, better-matching patients for trials in minutes, not months.

Deep 6 AI works with some of the most prominent health systems, pharma companies, and CROs in the world --making the DEEP 6 platform a crucial step in their clinical research workflow and greatly accelerating patients’ access to clinical trials. 

DEEP 6 AI was founded in 2015 and is based in Pasadena, CA.


Techstars

Cedars-Sinai Accelerator

Brooks Hill Partners

Point72 Ventures

GSR Ventures

Iaso Ventures

Summation Health Ventures

Thank you Marjorie Zettler, PhD, MPH at Accutar Biotech for moderating today's panel: Using RWD to Increase Patient Diversity in Clinical Trials. There were many takeaways including Deep 6 AI's CEO, Wout Brusselaers' perspective:

Too often, PIs at academic medical centers do not have diverse patient panels. Having PIs focus on recruiting patients from their panel is one of the biggest blockers to improving diversity in clinical trials. By leveraging #AI to mine #EMR data across a health system's entire network we can find eligible patients seen by physicians at sites in underserved communities. And we can allow physicians treating diverse patients to see which trials their patients are eligible for in their EMR and refer them to a PI within their network.

Dyan Bryson
Jen Banks, MA, MA, PMP
Barry C. Leybovich


Deep 6 AI's CEO, Wout Brusselaers, is at #SCOPEsummit discussing how sponsors have accelerated recruitment and generated RWE faster with our #AI-powered patient matching software and deep, real-time #EMR data.

Our CEO, Wout Brusselaers, is presenting today at 4:10 pm in the RWE track at #SCOPEsummit. Come hear case studies about sponsors that have accelerated patient recruitment with #AI.

Start your morning right with an espresso drink ☕ at booth #1035.

Timothy Keliher, John Harvey, Melissa Collins, Antonia Holway, Allison McKinley, Daniel Calvert, Wout Brusselaers.

#SCOPEsummit

Metric
Company Name	Deep 6 AI	Accelerated Enrollment Solutions (AES)	Massive Bioinformatics	OneStudyTeam
Symbol
MSH ID	AI:DEEP6	COM:GLOBALAES	COM:MASSIVEBIOINFORMATICS	COM:ONESTUDYTEAM
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Healthcare Technology	Clinical Research	Biotechnology	Clinical Research
Country	US	US	TR	US
Stage
Employee Count	58
Website	deep6.ai	globalaes.com	massivebioinformatics.com	onestudyteam.com
LinkedIn	deep-6-ai
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

AI:DEEP6

Deep 6 AI

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue